Gene Biotherapeutics, Inc. Stock Other OTC
Equities
CRXM
US8767671048
Biotechnology & Medical Research
Sales 2019 | - | Sales 2020 | - | Capitalization | 551K 753K |
---|---|---|---|---|---|
Net income 2019 | - 0 | Net income 2020 | - 0 | EV / Sales 2019 | - |
Net Debt 2019 | 1.12M 1.53M | Net Debt 2020 | 874K 1.2M | EV / Sales 2020 | - |
P/E ratio 2019 |
3.09
x | P/E ratio 2020 |
-1.77
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 93.84% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 70 | 03-12-21 | |
James Grainer
CHM | Chairman | 69 | 20-05-21 |
Lois Chandler
COO | Chief Operating Officer | - | 10-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 70 | 03-12-21 | |
James Grainer
CHM | Chairman | 69 | 20-05-21 |
Ronald Shebuski
CTO | Chief Tech/Sci/R&D Officer | 71 | 20-05-21 |
1st Jan change | Capi. | |
---|---|---|
+23.51% | 44.96B | |
+0.51% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+11.01% | 26.08B | |
-21.22% | 19.03B | |
+6.35% | 12.75B | |
+29.05% | 12.06B | |
-3.53% | 11.75B |